• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Synaptic localization of striatal NMDA, quisqualate and kainate receptors.

作者信息

Greenamyre J T, Young A B

机构信息

Department of Neurology, University of Michigan, Ann Arbor 48104.

出版信息

Neurosci Lett. 1989 Jun 19;101(2):133-7. doi: 10.1016/0304-3940(89)90519-3.

DOI:10.1016/0304-3940(89)90519-3
PMID:2549458
Abstract

Striatal binding of labeled glutamate to N-methyl-D-aspartate (NMDA) receptors, D,L-alpha-amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid (AMPA) to quisqualate receptors and kainate to kainate receptors was examined in rats which had received unilateral decortications or unilateral striatal quinolinic acid lesions. One week after decortication, there were no significant changes in NMDA, quisqualate or kainate receptors in the striatum ipsilateral to the lesion, when compared to the striatum contralateral to the lesion. In contrast, binding to NMDA receptors was reduced by 92%, to quisqualate receptors by 80% and to kainate receptors by 81% in striatum 3 months after quinolinic acid lesions. The reduction in NMDA receptor binding was significantly greater than the loss of quisqualate or kainate receptors. These results suggest that NMDA, quisqualate and kainate receptor recognition sites are located postsynaptically in the striatum. These results also have implications for the quinolinic acid model of Huntington's disease.

摘要

相似文献

1
Synaptic localization of striatal NMDA, quisqualate and kainate receptors.
Neurosci Lett. 1989 Jun 19;101(2):133-7. doi: 10.1016/0304-3940(89)90519-3.
2
Selective alterations in glutamate receptor subtypes after unilateral orbital enucleation.单侧眼眶摘除术后谷氨酸受体亚型的选择性改变。
Brain Res. 1991 Feb 1;540(1-2):255-65. doi: 10.1016/0006-8993(91)90515-w.
3
Changes in excitatory amino acid receptor binding in the intact and decorticated rat neostriatum following insulin-induced hypoglycemia.胰岛素诱导低血糖后完整及去皮质大鼠新纹状体中兴奋性氨基酸受体结合的变化。
J Neurochem. 1989 May;52(5):1340-7. doi: 10.1111/j.1471-4159.1989.tb09177.x.
4
Vinpocetine preferentially antagonizes quisqualate/AMPA receptor responses: evidence from release and ligand binding studies.
Eur J Pharmacol. 1991 Dec 10;209(1-2):109-12. doi: 10.1016/0014-2999(91)90019-m.
5
L-[3H]Glutamate binds to kainate-, NMDA- and AMPA-sensitive binding sites: an autoradiographic analysis.L-[3H]谷氨酸与对 kainate、NMDA 和 AMPA 敏感的结合位点结合:放射自显影分析。
Brain Res. 1985 Aug 12;340(2):378-83. doi: 10.1016/0006-8993(85)90936-9.
6
Selective loss of N-methyl-D-aspartate-sensitive L-[3H]glutamate binding sites in rat brain following portacaval anastomosis.
J Neurochem. 1990 Aug;55(2):386-90. doi: 10.1111/j.1471-4159.1990.tb04149.x.
7
Modulation of DL-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA)/quisqualate receptors by phospholipase A2 treatment.磷脂酶A2处理对DL-α-氨基-3-羟基-5-甲基异恶唑-4-丙酸(AMPA)/quisqualate受体的调节作用
Neurosci Lett. 1990 Oct 16;118(2):245-8. doi: 10.1016/0304-3940(90)90638-p.
8
Excitatory amino acid binding sites in the caudate nucleus and frontal cortex of Huntington's disease.亨廷顿病尾状核与额叶皮质中的兴奋性氨基酸结合位点
Ann Neurol. 1991 Dec;30(6):785-93. doi: 10.1002/ana.410300607.
9
Presynaptic facilitation of dopamine release through D,L-alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptors on synaptosomes from the rat striatum.通过大鼠纹状体突触体上的D,L-α-氨基-3-羟基-5-甲基-4-异恶唑丙酸受体对多巴胺释放的突触前易化作用。
J Pharmacol Exp Ther. 1991 Nov;259(2):692-8.
10
Kynurenic acid and quinolinic acid act at N-methyl-D-aspartate receptors in the rat hippocampus.犬尿喹啉酸和喹啉酸作用于大鼠海马体中的N-甲基-D-天冬氨酸受体。
J Pharmacol Exp Ther. 1986 Jan;236(1):293-9.

引用本文的文献

1
Excitatory amino acidergic pathways and receptors in the basal ganglia.基底神经节中的兴奋性氨基酸能通路和受体。
Amino Acids. 1991 Oct;1(3):339-50. doi: 10.1007/BF00814003.
2
Cortical ionotropic glutamate receptor antagonism protects against methamphetamine-induced striatal neurotoxicity.皮质离子型谷氨酸受体拮抗作用可预防甲基苯丙胺诱导的纹状体神经毒性。
Neuroscience. 2011 Dec 29;199:272-83. doi: 10.1016/j.neuroscience.2011.09.014. Epub 2011 Sep 16.
3
Striatal dopamine and glutamate receptors modulate methamphetamine-induced cortical Fos expression.
纹状体多巴胺和谷氨酸受体调节甲基苯丙胺诱导的皮质Fos表达。
Neuroscience. 2009 Jul 21;161(4):1114-25. doi: 10.1016/j.neuroscience.2009.04.023. Epub 2009 Apr 15.
4
Further evidence for the subsensitivity of striatal AMPA receptors, induced by chronic haloperidol administration: an autoradiographic study.
Naunyn Schmiedebergs Arch Pharmacol. 1996 Aug-Sep;354(3):384-8. doi: 10.1007/BF00171073.
5
Regulation of N-methyl-D-aspartate receptor-mediated calcium transport and norepinephrine release in rat hippocampus synaptosomes by polyamines.多胺对大鼠海马突触体中N-甲基-D-天冬氨酸受体介导的钙转运和去甲肾上腺素释放的调节作用
Neurochem Res. 1994 Nov;19(11):1421-9. doi: 10.1007/BF00972471.
6
Glutamate-dopamine interactions in the ventral striatum: role in locomotor activity and responding with conditioned reinforcement.腹侧纹状体中谷氨酸与多巴胺的相互作用:对运动活动及条件性强化反应的作用
Psychopharmacology (Berl). 1994 Aug;115(4):516-28. doi: 10.1007/BF02245576.
7
NMDA-induced glutamate and aspartate release from rat cortical pyramidal neurones: evidence for modulation by a 5-HT1A antagonist.N-甲基-D-天冬氨酸诱导大鼠皮层锥体神经元释放谷氨酸和天冬氨酸:5-羟色胺1A拮抗剂调节作用的证据。
Br J Pharmacol. 1995 Aug;115(7):1169-74. doi: 10.1111/j.1476-5381.1995.tb15020.x.
8
Kainic acid neurotoxicity: in vivo test of two new non-N-methyl-D-aspartate receptor antagonists.
Acta Neuropathol. 1991;81(3):255-60. doi: 10.1007/BF00305866.
9
Contribution of NMDA receptors to postsynaptic potentials and paired-pulse facilitation in identified neurons of the rat nucleus accumbens in vitro.
Exp Brain Res. 1991;86(1):190-8. doi: 10.1007/BF00231053.
10
R-(+)-HA-966, a glycine/NMDA receptor antagonist, selectively blocks the activation of the mesolimbic dopamine system by amphetamine.R-(+)-HA-966,一种甘氨酸/N-甲基-D-天冬氨酸受体拮抗剂,可选择性阻断苯丙胺对中脑边缘多巴胺系统的激活。
Br J Pharmacol. 1991 Aug;103(4):2037-44. doi: 10.1111/j.1476-5381.1991.tb12372.x.